Insider · CIK 0001606241

Brady Stephen R

Reports to the SEC for 3 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001606241

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-01-02	TPSTTempest Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+550K sh	—	—	550,000
2024-07-03	TPSTTempest Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+35K sh	$2.11	+$73.9K	46,376
2024-01-03	TPSTTempest Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+250K sh	—	—	250,000
2023-10-11	TPSTTempest Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+725K sh	—	—	725,000
2023-06-13	Atreca, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2023-01-03	TPSTTempest Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+177K sh	—	—	177,300
2022-06-21	TPSTTempest Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+174K sh	—	—	173,533
2022-06-08	Atreca, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2022-01-04	TPSTTempest Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+94.5K sh	—	—	94,500
2021-07-14	Atreca, Inc.Stock Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,000
2021-06-25	TPSTTempest Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.98M sh	—	—	1,982,250
2021-06-25	TPSTTempest Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+8,050 sh	—	—	8,050
2021-06-25	TPSTTempest Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+70.3K sh	—	—	70,256
2021-06-25	TPSTTempest Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+110K sh	—	—	110,432
2019-04-02	IMMUNE DESIGN CORP.Restricted Stock UnitsD Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−79.5K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−117K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−100K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−184K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−120K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−17.1K sh	$5.85	−$99.8K	0
2019-01-07	IMMUNE DESIGN CORP.S Sale	EVP, Strategy & Finance	SSale	−5,516 sh	$1.58	−$8,721.899	96,599
2019-01-03	IMMUNE DESIGN CORP.A Award	EVP, Strategy & Finance	AAward	+25K sh	—	—	102,115
2019-01-03	IMMUNE DESIGN CORP.Stock Option (right to buy)A Award	EVP, Strategy & Finance	AAward	+120K sh	—	—	120,000
2018-11-07	IMMUNE DESIGN CORP.A Award	EVP, Strategy & Finance	AAward	+30K sh	—	—	77,115
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	EVP, Strategy & Finance	AAward	+9,478 sh	—	—	9,478
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−27.5K sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	EVP, Strategy & Finance	AAward	+18.4K sh	—	—	18,350
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−12.2K sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	EVP, Strategy & Finance	AAward	+8,154 sh	—	—	8,154
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−2,838 sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	EVP, Strategy & Finance	AAward	+1,419 sh	—	—	1,419
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−47.2K sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	EVP, Strategy & Finance	AAward	+23.6K sh	—	—	23,581
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−50K sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	EVP, Strategy & Finance	AAward	+33.3K sh	—	—	33,334
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−5,054 sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	EVP, Strategy & Finance	AAward	+2,888 sh	—	—	2,888
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−69.9K sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	EVP, Strategy & Finance	AAward	+40K sh	—	—	39,970
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−14.2K sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	EVP, Strategy & Finance	DDisposition to Issuer	−70.8K sh	—	—	0
2018-07-17	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)A Award	EVP, Strategy & Finance	AAward	+47.2K sh	—	—	47,190
2017-01-04	IMMUNE DESIGN CORP.Stock Option (right to buy)A Award	EVP, Strategy & Finance	AAward	+85K sh	—	—	85,000
2017-01-04	IMMUNE DESIGN CORP.S Sale	EVP, Strategy & Finance	SSale	−1,642 sh	$5.35	−$8,784.7	30,490
2017-01-04	IMMUNE DESIGN CORP.A Award	EVP, Strategy & Finance	AAward	+15K sh	—	—	32,132
2016-07-15	IMMUNE DESIGN CORP.P Purchase	EVP, Strategy & Finance	PPurchase	+1,500 sh	$6.84	+$10.3K	17,132
2016-01-04	IMMUNE DESIGN CORP.Employee Stock Option (right to buy)A Award	EVP, Strategy & Finance	AAward	+75K sh	—	—	75,000
2016-01-04	IMMUNE DESIGN CORP.A Award	EVP, Strategy & Finance	AAward	+15K sh	—	—	15,632
2015-10-30	IMMUNE DESIGN CORP.Employee Stock Option (right to buy)A Award	EVP, Strategy & Finance	AAward	+50K sh	—	—	50,000
2015-01-07	IMMUNE DESIGN CORP.Employee Stock Option (right to buy)A Award	EVP, Strategy & Finance	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Jan 64
Brady Stephen R0001415889-25-000807
SEC(opens sec.gov)
Jul 84
Brady Stephen R0001415889-24-019339
SEC(opens sec.gov)
Jan 54
Brady Stephen R0001209191-24-001040
SEC(opens sec.gov)
Oct 134
Brady Stephen R0001209191-23-052783
SEC(opens sec.gov)
Jun 154
Brady Stephen R0001209191-23-037517
SEC(opens sec.gov)
Jan 54
Brady Stephen R0001209191-23-002144
SEC(opens sec.gov)
Jun 224
Brady Stephen R0001179110-22-003398
SEC(opens sec.gov)
Jun 104
Brady Stephen R0001209191-22-036107
SEC(opens sec.gov)
Jan 64
Brady Stephen R0001209191-22-002247
SEC(opens sec.gov)
Jul 164
Brady Stephen R0001209191-21-047021
SEC(opens sec.gov)
Jun 294
Brady Stephen R0001140361-21-022783
SEC(opens sec.gov)
Apr 44
Brady Stephen R0001209191-19-023687
SEC(opens sec.gov)

Companies

Address

C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E, SUITE 310

SEATTLE, WA, 98102